Keyword: pharmaceutical industry India
News
01.06.2013
- India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...
News
02.04.2013
- India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...
News
27.03.2013
- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...
News
13.02.2013
- Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...
News
05.02.2013
- GlaxoSmithKline has lifted its stake in its publicly-listed Indian consumer healthcare subsidiary to 72.5% from 43.2%, deepening its footprint in emerging markets and non...
News
30.11.2012
- German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...
News
30.11.2012
- Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent...
News
26.11.2012
- GlaxoSmithKline plans to buy up to an additional 31.8% stake in its Indian consumer products arm for about $940 million, as Britain's biggest drugmaker deepens its emerging markets...
